期刊文献+

反义核酸逆转Hep-2v细胞多药耐药的研究 被引量:1

The reversal of multidrug resistance in Hep-2v cell line by antisense oligodeoxynucleotides
下载PDF
导出
摘要 目的 :探讨克服肿瘤细胞的多药耐药 (multidrugresistance ,MDR)的有效方法。方法 :用反义硫代磷酸寡聚脱氧核苷酸 (asODN)对Hep - 2v细胞进行多药耐药 (MDR)逆转实验 ,(1)将Hep - 2细胞经长春新碱(VCR)筛选建立Hep - 2v耐药细胞株为靶细胞 ;(2 )针对mdr1mRNA序列计算机辅助设计人工合成两个15mer反义寡聚脱氧核苷酸序列 :asODNⅠ、Ⅱ ,以硫代法修饰 ,其中序列Ⅰ和Ⅱ的作用位点相邻接 ,互补位点为MDR -mRNA的 330~ 35 9碱基 ;(3)MDR逆转实验 :两个反义序列分别或联合作用于Hep - 2v细胞 ,MTT法测定反义核酸作用前后VCR对Hep - 2v细胞IC50 ,比较其细胞毒作用 ;用流式细胞仪 (FCM )检测反义核酸作用后各实验组细胞表面糖蛋白P - 170的阳性率 ;RT -PCR法检测mdr1mRNA表达水平。结果 :两个反义核酸均使Hep - 2v细胞的P - 170阳性率下降 ,mdr1mRNA水平低调 ,VCR对Hep - 2v的细胞毒作用IC50 从90 0nmol L降至 <2 0 0nmol L。结论 :两个反义核酸用于Hep - 2v的MDR均获得明显的逆转效果 ,序列Ⅰ +Ⅱ联合作用的效果更强 。 Objective: To investigate the effectiveness of the antisense phosphorothioate oligonucleotides(asODN) in reversal of multidrug resistance in Hep-2v cell line. Methods: (1)The MDR cell line Hep-2v, selected by vincristine(VCR), was used as the target for this study. (2)Two 15mer antisense phosphorothoate oligodeoxynucleotides(asODN Ⅰ,Ⅱ) were designed against the mdr1-mRNA sequence. The two asODNs were tandem binding to bases from 330~359 of MDR1-mRNA. (3)The asODNs were administrated to the different group of the cultured Hep-2v cells. Quantitative analysis of P-170 was made by flow cytometry, and the level of mdr1-mRNA of the cells was detected by RT-PCR. The cellular toxicity of VCR was determined by MTT method.Results: The reversal of MDR was obtained effectively in the cell line after applied the asODNs. FCM indicated that P-170 was significantly reduced in the MDR cells. RT-PCR showed that the level of mdr1-mRNA in Hep-2v cells was down-regulated, and the IC 50 of VCR was decreased from about 900nmol/L to 200nmol/L. The more efficience was observed in the group of combined application of asODNⅠ and Ⅱ comparing with the use of asODN Ⅰor Ⅱ singly (P<0.05). Conclusions: Significantly reversal of MDR in Hep-2v cell line is obtained by using of the two asODNs. The more efficiency is observed in the test cell of combined application of asODNⅠand Ⅱ.It is suggested that the oligomers that are designed to bind in tandem to the target sites may have a synergic effect.
出处 《山东大学基础医学院学报》 CAS 2004年第6期321-324,共4页 Journal of Preclinical Medicine College of Shandong Medical University
关键词 抗药性 多药 咽肿瘤 寡脱氧核糖核苷酸类 反义 Drug resistance,multiple Pharyngeal neoplasms Oligodeoxynucleotides,antisense
  • 相关文献

参考文献12

  • 1Kane SE,Pastan I,Gottesman MM.Genetic basis of drug resistance of tumour cells[J].J Bioeneg Biomem,1990,22:593-596.
  • 2Van der Bliek AM,Borst P.Multidrug resistance[J].Adv Cancer Res,1989,52:165-203.
  • 3蔡晓岚,王天铎,史丽.喉咽癌患者多药耐药基因多药耐药相关蛋白基因的表达及其临床意义[J].中华耳鼻咽喉科杂志,1999,34(3):173-176. 被引量:7
  • 4黄建民,林国经,栾信庸.下咽癌Hep-2v多药耐药细胞株的筛选[J].福建医药杂志,2003,25(6):1-3. 被引量:1
  • 5Stein CA.How to design an antisense oligodeoxynucleotide experiment:a consensus approach[J].Antisense & Nucleic Acid Drug Development,1998,8:129-132.
  • 6Miller TP,Grogan TM,Dalton WS,et al.P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapmil[J].J Clin Oncol,1991,9:7.
  • 7Hogrefe RI.an Antisense oligonucleotide primer[J].Antisense & Nucleic Acid Development,1999,9:351-357.
  • 8Crooke ST.An overview of progress in antisense therapeutics[J].Antisense & Nucleic Acid Drug Development,1998,8:115-122.
  • 9Rivoltini L,Colombo MP,Supino R,et al.Modulation of multidrug resistance by verapamil or mdr1 antisense oligodeoxynucleotides does not change the high susceptibility to lymphokine-activated kills in mdr-resistant human carcinoma(LoVo) line[J].Int J Cancer,1990,46:727-732.
  • 10Ramachandran C,Wellham LL.Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts[J].Anticancer Res,2003,23:2681-2690.

二级参考文献2

  • 1Susan E. Kane,Ira Pastan,Michael M. Gottesman. Genetic basis of multidrug resistance of tumor cells[J] 1990,Journal of Bioenergetics and Biomembranes(4):593~618
  • 2Shin-ichi Akiyama,Antonio Fojo,John A. Hanover,Ira Pastan,Michael M. Gottesman. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs[J] 1985,Somatic Cell and Molecular Genetics(2):117~126

共引文献6

同被引文献10

  • 1胡礼仪,张有顺,周新,张吉发,袁房均,黄玲,王菊,戴宗晴.MDR1短发夹RNA表达质粒的构建及其功能的初步研究[J].肿瘤,2004,24(6):542-545. 被引量:4
  • 2李臣宾,张峰,史玉荣,魏熙胤,杨毅,牛瑞芳.siRNA逆转乳腺癌细胞系MCF-7/ADR耐药[J].癌症,2004,23(12):1605-1610. 被引量:6
  • 3Krishna R,Mayer L D.Multidrug resistance(MDR) in cancer,mechanisms,reversal using modulators of MDR and the role of MDR modulators in influencing the phamacokinetics of anticancer srug [J].EurJ Pharm Sci,2000,11 (4):265 -283.
  • 4Coley H M,Vevrill M W,Gregson S E.Inciduce of P - glycoprotein over expression and multidrug resistance (MDR)reversal in adult soft tissue sarcoma[J].EurJ Cancer,2000,36(7) :881 -888.
  • 5Mistry P,Stewart A J,Dangerfield W,et al.In vitro and in vivo reversal of P - glycoprotein - mediated multidrug resistance by a novel potent modulator,XR9576 [J].Cancer Res,2001,61 (2) :749 -758.
  • 6Marthinet E,Divita G ,Bernaud J,et al.Modulation of the typical multidrug resistance phenotype by targeting the MED -1 region of human mdr1 promoter[J].Gene Ther,2000,7 (14) :1224.
  • 7Kobayashi H,Takemura Y,Wang FS,et al.Retrovirus - mediated transger of anti - MDR1 hammerhead ribozymes into multidrug -resistant human leukemia cells:screening for effective target sites [J].IntJ Cancer,1999,81 (6) :944.
  • 8Hao W U,William N Hait.Small Interfering RNA - induced Suppression of MDR1 (P - Glycoprotein) Restores Sensitivity to Multidrug -resistant Cancer Cells[J].Cabcer Research,2003,(63) :1515 -1519.
  • 9Celius T,Garberg P,Lundgren B.Stable suppression of MDR1 gene expression and function by RNAi in Caco - 2 cells [J].Biochem Biophys Res Commun,2004,324(1) :365 -371.
  • 10王海,陈孝平,裘法祖.核酶对人肝癌细胞多药耐药性的逆转[J].中华外科杂志,2004,42(7):424-427. 被引量:8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部